152 related articles for article (PubMed ID: 35218177)
21. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
[TBL] [Abstract][Full Text] [Related]
22. Measuring methotrexate polyglutamates.
Goodman S
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S24-6. PubMed ID: 21044429
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
[TBL] [Abstract][Full Text] [Related]
24. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
Angelis-Stoforidis P; Vajda FJ; Christophidis N
Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
[TBL] [Abstract][Full Text] [Related]
26. Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response.
Haagsma CJ; Russel FG; Vree TB; Van Riel PL; Van de Putte LB
Br J Clin Pharmacol; 1996 Aug; 42(2):195-200. PubMed ID: 8864317
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients.
Yukawa E; Mori S; Ueda K; Nakada Y
J Clin Pharm Ther; 2007 Dec; 32(6):573-8. PubMed ID: 18021334
[TBL] [Abstract][Full Text] [Related]
29. Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.
Meesters RJ; den Boer E; de Jonge R; Lindemans J; Luider TM
Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3063-70. PubMed ID: 21953961
[TBL] [Abstract][Full Text] [Related]
30. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639
[TBL] [Abstract][Full Text] [Related]
31. The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
Becker ML; Gaedigk R; van Haandel L; Thomas B; Lasky A; Hoeltzel M; Dai H; Stobaugh J; Leeder JS
Arthritis Rheum; 2011 Jan; 63(1):276-85. PubMed ID: 20954192
[TBL] [Abstract][Full Text] [Related]
32. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
[TBL] [Abstract][Full Text] [Related]
33. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
34. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
[TBL] [Abstract][Full Text] [Related]
35. Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
Stamp LK; Roberts RL
Pharmacogenomics; 2011 Oct; 12(10):1449-63. PubMed ID: 22008049
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
[TBL] [Abstract][Full Text] [Related]
37. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial.
Hebing RC; Lin M; Bulatovic Calasan M; Muller IB; Mahmoud S; Heil S; Struys EA; van den Bemt BJ; Twisk JW; Lems W; Nurmohamed MT; Jansen G; de Jonge R
Ann Rheum Dis; 2023 Apr; 82(4):460-467. PubMed ID: 36543526
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
[TBL] [Abstract][Full Text] [Related]
40. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.
Wang W; Zhou H; Liu L
Eur J Med Chem; 2018 Oct; 158():502-516. PubMed ID: 30243154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]